THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
发明人:
BOOTHMAN, DAVID,GAO, JINMING,BEY, ERIK,DONG, YING
申请号：
EP11827555
公开号：
EP2619331A4
申请日:
2011.09.22
申请国别(地区):
EP
年份:
2014
代理人:
摘要：
Disclosed herein are methods for determining whether an individual with cancer is suitable for a treatment with an NQO1 bioactivatable drug, predicting responsiveness of an individual with cancer to a treatment with an NQO1 bioactivatable drug, and treating an individual with cancer with an NQO1 bioactivatable drug composition.
